Massmedica S.A. (WSE:MSM)

Market Cap	10.63M +4.8%
Revenue (ttm)	31.94M +2.5%
Net Income	679.32K -9.9%
EPS	0.28
Shares Out	2.41M
PE Ratio	15.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	662
Open	4.650
Previous Close	4.670
Day's Range	4.250 - 4.650
52-Week Range	3.260 - 7.500
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Massmedica

Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases, aesthetic and regenerative medicines in Poland. It offers products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company’s products include dietary supplements, skin care cosmetics, sun protection creams, tools, serum, masks, carboxytheraphy, and intra-articular injections for regeneration of the knee joints. It also provides reconstructive products, such as hip end...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 2011
• Employees: 14
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MSM

Financial Performance

In 2025, Massmedica's revenue was 32.22 million, a decrease of -1.20% compared to the previous year's 32.61 million. Earnings were 535,808, a decrease of -11.23%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 9, 2026

Data Sources Report a data error